Ticker: TSX - TOS
Shares Outstanding: 46,244,102
QUEBEC CITY, Oct. 26 /CNW Telbec/ - TSO3 Inc. ("TSO3") (TSX: TOS) today
announced that it will report financial results for the third quarter 2007
ended September 30, 2007, on Friday, November 9, 2007.
TSO3 will host a Conference Call at 10:00 A.M. (ET), on November 9, 2007.
Analysts and institutional investors are invited to participate. The numbers
to dial for access are (514) 807-8791 (Montréal area), (416) 644-3425 (Toronto
area) or the toll-free number 1-800-594-3790.
Other Interested parties may listen to the live Webcast of the Conference
Call accessible via TSO3's Website at: www.tso3.com. The Webcast will be
archived for 90 days.
TSO3, founded in Québec City in 1998, specializes in the research and
development of innovative, high-performance medical instrument sterilization
technology whit high commercial potential. The Company's first product, the
125L Ozone Sterilizer, is designed for sterile processing centers in the
In contrast to other methods used, the ozone sterilization process
developed and patented by TSO3 meets all standards required by the evolution
in sterilization needs, which are: significant costs savings, increased safety
for patients and hospital staff, and a "green" environmentally safe process.
The Company believes that its technology represents an advantageous
replacement solution to other low temperature sterilization processes
currently used in hospitals.
The 125L Ozone Sterilizer is cleared for commercialization by the US Food
and Drug Administration and by Health Canada. TSO3 is in commercialization
phase for this first product since 2006.
TSO3 currently has more than 65 employees, about half of whom work in the
sales and marketing team.
For more information about TSO3, visit the Company's Web site at
For further information:
For further information: Caroline Côté, Director, Corporate
Communications & IR, (418) 651-0003, Ext. 237, firstname.lastname@example.org; Source: TSO3